TITLE

Reply to Johnson

AUTHOR(S)
Barlesi, Fabrice; Doddoli, Christophe; Kleisbauer, Jean-Pierre; Thomas, Pascal
PUB. DATE
January 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Jan2004, Vol. 25 Issue 1, p148
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
11733164

 

Related Articles

  • Johnson's `reply to impromptu verses by Baretti': A clue... Dingley, R.J. // Notes & Queries;Dec95, Vol. 42 Issue 4, p468 

    The article offers criticism on the poem "Reply to Impromptu Verses by Baretti" by Samuel Johnson.

  • Johnson & Johnson In Market For $1.2B. Phadungchai, Naruth // Bank Loan Report;09/13/99, Vol. 14 Issue 36, p3 

    Reports on the credit facility launched by Citibank, Bank of Montreal, Chase Manhattan and Morgan Stanley Dean Witter for Johnson & Johnson. Details on the facility; Deadline on the replies.

  • Just war. Miller, Richard // Bulletin of the Atomic Scientists;Oct1985, Vol. 41 Issue 9, p57 

    Replies to the comments of J. Johnson concerning the author's review of the books 'Can Modern War Be Just?' and 'Moral Principles of Nuclear Weapons.'

  • Gauging.  // Modern Railways;Feb2010, Vol. 67 Issue 737, p12 

    The article features a reply to the reaction of Laser Rail former head David Johnson on comments on gauging made by the journal in a previous issue.

  • Just War Today.  // First Things: A Monthly Journal of Religion & Public Life;Apr2005, Issue 152, p7 

    Presents a reply by James Turner Johnson to letters to the editor about his article "Just War, As It Was and Is," in the January 2005 issue of the journal.

  • Author's Reply. Mazumdar, G.; Chogtu, Bharti // Indian Journal of Pharmacology;Sep/Oct2014, Vol. 46 Issue 5, p565 

    A reply to a letter to the editor about Stevens Johnson syndrome (SJS), a severe cutaneous adverse drug reaction and predominantly involves the skin and mucous membranes, is presented.

  • Johnson & Johnson's. Investor's Business Daily // Investors Business Daily;3/ 9/2012, pA02 

    Johnson &

  • Johnson & Johnson. Investor's Business Daily // Investors Business Daily;6/ 1/2012, pA02 

    Johnson &

  • Johnson & Johnson. Investor's Business Daily // Investors Business Daily;6/12/2012, pA02 

    Johnson &

  • J&J resolves fraud claims. Investor's Business Daily // Investors Business Daily;8/31/2012, pA02 

    Johnson &

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics